Paper Details

  1. Home
  2. Paper Details

A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.

Author: BorisonR L, ChouinardG, MöllerH J, MüllerH, SchoolerN R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Risperidone was more effective than haloperidol in reducing negative symptoms in schizophrenia, but this could not be fully explained by its effects on positive or extrapyramidal symptoms. Risperidone showed a favorable effect on positive and extrapyramidal symptoms compared to haloperidone.
Paper Details　
Original Abstract of the Article :
The hypothesis that differences in drug effects of risperidone and haloperidol on negative symptoms in schizophrenia are secondary to effects on positive, extrapyramidal, and depressive symptoms was investigated by means of an analysis of the data from the USA-Canada risperidone double-blind randomi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF02191543

データ提供：米国国立医学図書館（NLM）

Risperidone: A More Effective Treatment for Negative Symptoms in Schizophrenia?

Schizophrenia is a complex mental illness that can significantly affect a person's life. This study investigates the effectiveness of risperidone and haloperidol, two common antipsychotic medications, in treating negative symptoms of schizophrenia. The study found that risperidone was more effective in reducing negative symptoms, even after accounting for its effects on other symptoms. These findings suggest that risperidone may be a better treatment option for negative symptoms in schizophrenia.

Understanding the Nuances of Schizophrenia Treatment

This study highlights the importance of considering the different symptom profiles of schizophrenia and the potential benefits of targeted treatment approaches. While both risperidone and haloperidol are effective for treating positive symptoms, risperidone appears to be more effective for managing negative symptoms.

Health Implications and Lifestyle Applications

This research emphasizes the importance of individualized treatment plans for those with schizophrenia. By understanding the different symptom profiles and the potential benefits of various medications, healthcare professionals can tailor treatment to meet the specific needs of each patient. It also encourages individuals with schizophrenia to work closely with their healthcare provider to find the most effective treatment approach.

Dr.Camel's Conclusion

This study is like a journey through the vast and complex desert of schizophrenia, revealing new insights into the effectiveness of different treatment approaches. It demonstrates the importance of considering the individual needs of each patient and exploring various options to find the best path to recovery. Just as a camel navigates the desert with its own unique strengths and strategies, healthcare professionals must find the right tools and resources to help individuals with schizophrenia navigate the challenges of their condition.

Date :
  1. Date Completed 1995-07-27
  2. Date Revised 2019-10-31
Further Info :

Pubmed ID

7540426

DOI: Digital Object Identifier

10.1007/BF02191543

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.